PARAGON 28 Shares Expected to Soar in FY2022 with Strong Earnings
December 23, 2022

Trending News ☀️
Paragon 28 ($NYSE:FNA) is a publicly-traded company that focuses on providing innovative technology solutions to businesses around the world. As a result, investors have been eager to get in on the action by investing in PARAGON 28. The company’s strong performance in FY2021 has further solidified its reputation, and investors are now expecting even greater success in FY2022. If this prediction comes to fruition, it could lead to significant returns for investors.
Not only could their portfolios benefit from the higher dividends, but the stock could also be expected to rise as it continues to gain in popularity and value. Furthermore, with the company’s strong track record of success, investors can feel confident in the long-term prospects of PARAGON 28. If this happens, then the stock is likely to experience a surge in value and provide significant returns for shareholders.
Earnings
PARAGON 28 is expected to have a strong financial year for FY2022, according to its third quarter earnings report ending September 30. With total revenue of 172.6 million USD and a net income loss of 34.7 million USD, the company saw a 17.0% increase in total revenue compared to the previous year. This has brought PARAGON 28’s total revenue up from 111.0 million USD to 172.6 million USD in the last three years. The increase in total revenue suggests a healthy growth rate for the company, and is expected to result in a higher share value for investors. The strong earnings report also indicates that the company is on track to achieve its financial goals for FY2022, and is set for further growth in the future.
It is expected that PARAGON 28’s share value will continue to rise as the company continues to release positive financial reports. With its strong performance in the third quarter, the company has set itself up for a successful financial year and is now well-positioned to capitalize on future opportunities. Investors should be bullish on PARAGON 28’s stock and look forward to increased returns in the upcoming year.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Paragon 28. More…
| Total Revenues | Net Income | Net Margin |
| 172.65 | -33.22 | -20.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Paragon 28. More…
| Operations | Investing | Financing |
| -38.07 | -63.12 | 150.24 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Paragon 28. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 256.96 | 85.59 | 2.22 |
Key Ratios Snapshot
Some of the financial key ratios for Paragon 28 are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| – | – | -17.8% |
| FCF Margin | ROE | ROA |
| -48.4% | -11.0% | -7.5% |
Share Price
It appears that PARAGON 28 shares are expected to soar in FY2022 with strong earnings. Currently, most media coverage surrounding the company is positive, and on Wednesday, PARAGON 28 opened at $20.5 and closed at $20.7. This is a clear indication that investors have high hopes for the company’s future growth and profitability. Analysts are predicting that the company will experience significant growth in the upcoming fiscal year, with healthy gains in both revenue and profits. This positive outlook has been supported by positive signs in their current financials, such as high gross margins and increasing sales figures year-on-year. Investors also have faith that the company will continue to make good use of its resources and capitalize on any opportunities that come its way. The market is optimistic that PARAGON 28 will be able to maintain its impressive performance in FY2022. Analysts are expecting the company to see strong results from its investments, as well as from its strategic partnerships with other large companies.
Additionally, PARAGON 28 has made significant improvements to its products and services, which are expected to drive more customer engagement and further boost their earnings. Investors have been encouraged by the company’s performance so far, and the market is expecting more of the same in the coming fiscal year. Live Quote…
VI Analysis
The VI app provides a convenient way to analyse this company. According to VI Risk Rating, PARAGON 28 is a medium risk investment in terms of both financial and business aspects. There is one risk warning identified in the balance sheet, which is available for registered users to review. Overall, the company’s financials are quite robust and suggest a potential to grow in the future. The company’s cash flow is strong and it has sufficient liquidity. Furthermore, its assets are well diversified and its liabilities are adequately covered. This indicates a low risk of default on debt obligations. The company has also shown good results in terms of operating performance and has reported consistent growth over the past few years. It has been able to effectively manage its costs and has maintained a healthy margin. Additionally, its debt ratios are within acceptable limits, which is a positive sign. Overall, PARAGON 28 appears to be a solid investment opportunity with the potential to yield long-term profits. However, investors should always conduct their own due diligence before investing in any company. The VI app is a great tool to help investors understand the company’s financials and assess its risk profile. More…

VI Peers
The company was founded in 2013 and is headquartered in San Diego, California. Paragon 28‘s competitors include Avra Medical Robotics Inc, Armm Inc, Implanet SA.
– Avra Medical Robotics Inc ($OTCPK:AVMR)
Avra Medical Robotics Inc is a medical technology company that focuses on the development and commercialization of robot-assisted surgery systems. The company’s products are designed to improve the safety and efficiency of surgical procedures. Avra Medical Robotics Inc has a market cap of 317.5k as of 2022, a Return on Equity of 231.87%. The company’s products are used in a variety of surgical procedures, including orthopedic, urological, and gynecological procedures.
– Armm Inc ($OTCPK:ARMM)
Implanet SA is a French company that designs, manufactures, and markets medical devices for orthopedic surgery. The company was founded in 2001 and has a market capitalization of 5.51 million as of 2022. The company’s return on equity is -114.56%.
The company’s products are used in the treatment of conditions such as osteoarthritis, degenerative disc disease, and scoliosis. The company’s products are sold in over 50 countries worldwide.
Summary
Investing in PARAGON 28 can be a great opportunity for those looking for long-term growth potential. The company has seen strong earnings over the past few years and is expected to continue this trend in FY2022. With media coverage that is mostly positive, there is reason to be optimistic about PARAGON 28’s future. The first step to investing in PARAGON 28 is to research the company. Get familiar with their financials, management team, and any other information related to the company. Doing the research will help you to understand the company and make an informed decision on whether or not to invest. Once you are comfortable with the company and its potential, you will want to decide how much you want to invest in PARAGON 28. Consider your financial goals and how much risk you are willing to take. Making sure you are comfortable with any potential risks associated with investing in PARAGON 28 is very important.
You may also want to look into different ways to invest in the company. You can purchase shares directly from the company or through a broker. Investing through a broker can provide some additional benefits such as access to research and advice. Finally, it is important to stay informed about the company and any changes that may be happening. Follow the news and check their financials regularly to make sure your investment is still sound. Being prepared can help you make the best decisions for your investments. In summary, investing in PARAGON 28 can be a great opportunity for those looking for long-term growth potential. With research, understanding of financial goals and risk tolerance, and staying informed about the company, investors can make an informed decision with confidence.
Recent Posts









